Related Articles
Delineation of retroperitoneal metastatic lymph nodes in ovarian cancer with near‑infrared fluorescence imaging
Expression of the tumor suppressor gene p16, and lymph node metastasis in patients with ovarian cancer
MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro
MTCH2 promotes the malignant progression of ovarian cancer through the upregulation of AIMP2 expression levels, mitochondrial dysfunction and by mediating energy metabolism
Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway